Ori Spotlight Episode Twelve – Adam Wieschhaus and Shaan Gandhi – Directors, Northpond Ventures

Episode Twelve

On Episode 12 of the Ori Spotlight Podcast Jason C. Foster sits down with Northpond Ventures, investor in both Ori’s Series A and Series B funding. We caught up with Directors Adam Wieschhaus and Shaan Gandhi, as they share their insights into the cell and gene therapy space. Northpond Ventures is a venture capitalist firm focused on life science, medicine, and technology; with 60 investments to date since its inception. Adam and Shaan lead their San Francisco and Boston offices respectively. Adam and Shaan sit down with Jason to discuss why bringing scalable cell and gene therapies to market is vital, the impact these therapies have on patients, and what excites them most about the investments made within the CGT space.

Learn more about Adam Wieschhaus and Shaan Gandhi

Related Articles

Ori Biotech Audio

Ori Spotlight Episode Eleven – Paul Meister, Partner at Novalis LifeSciences

Read more
Ori Spotlight Podcast - Farlan Veraitch
Ori Biotech Audio

Ori Spotlight Episode Ten – Farlan Veraitch, Co-Founder and Chief Scientific Officer at Ori Biotech

Read more
Ori Spotlight Podcast - Dr. Qasim Rafiq
Ori Biotech Audio

Ori Spotlight Episode Nine – Dr. Qasim Rafiq, Associate Professor of Cell and Gene Therapy Bioprocessing at University College London

Read more